Literature DB >> 26110474

Comparative determination of the efficacy of bispyridinium oximes in paraoxon poisoning.

Suzana Žunec, Božica Radić, Kamil Kuča, Kamil Musilek, Ana Lucić Vrdoljak.   

Abstract

The inability of standard therapy to provide adequate protection against poisoning by organophosphorus compounds (pesticides and nerve agents) motivated us to search for new, more effective oximes. We investigated the pharmacotoxicological properties of six experimental K-oximes (K027, K033, K048, K074, K075, and K203) in vivo. The therapeutic efficacy of K-oximes (at doses of 5 or 25 % of their LD50) combined with atropine was assessed in paraoxon-poisoned mice and compared with conventionally used oximes HI-6 and TMB-4. The bisoxime K074 was the most toxic (LD50=21.4 mg kg-1) to mice, while monoxime K027 was the least toxic (LD50=672.8 mg kg-1). With the exception of K033, all of the tested K-oximes showed better therapeutic efficiency than HI-6 and TMB-4. K027 and K048 stood out by demonstrating low acute toxicities and ensuring protective indices ranging from 60.0 to 100.0 LD50 of paraoxon. Taking into account that these two oximes showed a similar therapeutic efficacy regardless of the applied doses, our results suggest that K027 and K048 could be antidotes for paraoxon intoxication.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26110474     DOI: 10.1515/aiht-2015-66-2623

Source DB:  PubMed          Journal:  Arh Hig Rada Toksikol        ISSN: 0004-1254            Impact factor:   1.948


  5 in total

1.  Toxic Injury to Muscle Tissue of Rats Following Acute Oximes Exposure.

Authors:  Vesna Jaćević; Eugenie Nepovimova; Kamil Kuča
Journal:  Sci Rep       Date:  2019-02-06       Impact factor: 4.379

Review 2.  The Experimental Oxime K027-A Promising Protector From Organophosphate Pesticide Poisoning. A Review Comparing K027, K048, Pralidoxime, and Obidoxime.

Authors:  Dietrich E Lorke; Georg A Petroianu
Journal:  Front Neurosci       Date:  2019-05-22       Impact factor: 4.677

3.  Synthesis, in vitro screening and molecular docking of isoquinolinium-5-carbaldoximes as acetylcholinesterase and butyrylcholinesterase reactivators.

Authors:  David Malinak; Rafael Dolezal; Vendula Hepnarova; Miroslava Hozova; Rudolf Andrys; Petr Bzonek; Veronika Racakova; Jan Korabecny; Lukas Gorecki; Eva Mezeiova; Miroslav Psotka; Daniel Jun; Kamil Kuca; Kamil Musilek
Journal:  J Enzyme Inhib Med Chem       Date:  2020-12       Impact factor: 5.051

4.  Efficacy Assessment of an Uncharged Reactivator of NOP-Inhibited Acetylcholinesterase Based on Tetrahydroacridine Pyridine-Aldoxime Hybrid in Mouse Compared to Pralidoxime.

Authors:  André-Guilhem Calas; Anne-Sophie Hanak; Nina Jaffré; Aurélie Nervo; José Dias; Catherine Rousseau; Charlotte Courageux; Xavier Brazzolotto; Pascal Villa; Adeline Obrecht; Jean-François Goossens; Christophe Landry; Johan Hachani; Fabien Gosselet; Marie-Pierre Dehouck; Jagadeesh Yerri; Maria Kliachyna; Rachid Baati; Florian Nachon
Journal:  Biomolecules       Date:  2020-06-04

5.  Acute Toxic Injuries of Rat's Visceral Tissues Induced by Different Oximes.

Authors:  Vesna Jaćević; Eugenie Nepovimova; Kamil Kuča
Journal:  Sci Rep       Date:  2019-11-11       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.